Ligand Pharmaceuticals Inc
LGND· Nasdaq
LGNDLigand Pharmaceuticals Inc
Source filing unavailable
| Metric | Q4 2012 | Q4 2011dderived from reported figures | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|---|
| Revenue | $6.38M | $13.64M | $12.94M | — |
| Net Income | -$194.00K | $1.06M | $4.69M | — |
| EPS Diluted | -$0.01 | — | $0.24 | — |
Ligand Pharmaceuticals Inc · CIK 886163 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
